Quadrant Capital Group LLC Jazz Pharmaceuticals PLC Transaction History

Quadrant Capital Group LLC

$1.42 Billion
Q3 2024

A detailed history of Quadrant Capital Group LLC transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Quadrant Capital Group LLC holds 104 shares of JAZZ stock, worth $12,788. This represents 0.0% of its overall portfolio holdings.

Number of Shares

104

Previous 98 6.12%

Holding current value

$12,788

Previous $10,000 10.0%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$100.57 - $116.37 $603 - $698	6 Added 6.12%	104 $11,000
Q2 2024 Aug 12, 2024	SELL	$103.94 - $118.98 $32,221 - $36,883	-310 Reduced 75.98%	98 $10,000
Q1 2024 May 15, 2024	BUY	$115.19 - $132.77 $921 - $1,062	8 Added 2.0%	408 $49,000
Q4 2023 Feb 08, 2024	SELL	$114.26 - $136.0 $4,227 - $5,032	-37 Reduced 8.47%	400 $49,000
Q3 2023 Nov 14, 2023	SELL	$122.0 - $145.31 $14,396 - $17,146	-118 Reduced 21.26%	437 $56,000
Q2 2023 Aug 09, 2023	BUY	$122.5 - $147.16 $24,990 - $30,020	204 Added 58.12%	555 $68,000
Q1 2023 May 11, 2023	SELL	$133.98 - $160.47 $21,570 - $25,835	-161 Reduced 31.45%	351 $51,000
Q4 2022 Feb 10, 2023	BUY	$129.72 - $159.85 $38,526 - $47,475	297 Added 138.14%	512 $81,000
Q3 2022 Nov 10, 2022	BUY	$126.59 - $161.18 $12,912 - $16,440	102 Added 90.27%	215 $29,000
Q2 2022 Aug 09, 2022	BUY	$141.59 - $168.66 $3,398 - $4,047	24 Added 26.97%	113 $18,000
Q1 2022 May 06, 2022	BUY	$129.64 - $160.7 $2,333 - $2,892	18 Added 25.35%	89 $14,000
Q4 2021 Feb 01, 2022	SELL	$119.87 - $145.67 $10,548 - $12,818	-88 Reduced 55.35%	71 $9,000
Q3 2021 Nov 12, 2021	BUY	$128.64 - $184.79 $7,203 - $10,348	56 Added 54.37%	159 $21,000
Q2 2021 Aug 09, 2021	SELL	$160.2 - $186.42 $480 - $559	-3 Reduced 2.83%	103 $18,000
Q1 2021 May 12, 2021	SELL	$150.19 - $173.5 $28,085 - $32,444	-187 Reduced 63.82%	106 $17,000
Q4 2020 Feb 16, 2021	BUY	$140.71 - $165.05 $31,237 - $36,641	222 Added 312.68%	293 $48,000
Q3 2020 Nov 13, 2020	BUY	$105.46 - $144.13 $2,636 - $3,603	25 Added 54.35%	71 $10,000
Q2 2020 Aug 13, 2020	SELL	$95.68 - $121.88 $3,827 - $4,875	-40 Reduced 46.51%	46 $5,000
Q1 2020 May 15, 2020	SELL	$87.74 - $152.74 $26,146 - $45,516	-298 Reduced 77.6%	86 $8,000
Q4 2019 Feb 03, 2020	BUY	$117.65 - $153.73 $40,942 - $53,498	348 Added 966.67%	384 $55,000
Q3 2019 Oct 24, 2019	SELL	$125.18 - $143.24 $131,188 - $150,115	-1,048 Reduced 96.68%	36 $3,000
Q2 2019 Jul 24, 2019	BUY	$125.55 - $144.48 $39,799 - $45,800	317 Added 41.33%	1,084 $153,000
Q1 2019 Apr 29, 2019	BUY	$121.81 - $142.95 $82,952 - $97,348	681 Added 791.86%	767 $108,000
Q4 2018 Jan 17, 2019	BUY	$115.94 - $166.74 $2,086 - $3,001	18 Added 26.47%	86 $9,000
Q4 2017 Jan 31, 2018	BUY	$131.06 - $150.39 $6,946 - $7,970	53 Added 353.33%	68 $9,000
Q2 2017 Aug 15, 2017	BUY	N/A	15	15 $2,000

Others Institutions Holding JAZZ

# of Institutions

512

Shares Held

57.5M

Call Options Held

188K

Put Options Held

133K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.

Account

Quadrant Capital Group LLC Jazz Pharmaceuticals PLC Transaction History